Adalimumab
Brand name: Humira(Cf) Pen
Rank #6 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$2.17B
Total Cost
240,925
Total Claims
$2.17B
Total Cost
7,894
Prescribers
$8,997
Cost per Claim
11,221
Beneficiaries
252,309
30-Day Fills
$275K
Avg Cost/Provider
31
Avg Claims/Provider
Share of Medicare Part D Spending
0.79%
of total Medicare Part D spending
$2.17B of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $2.17B total
🔎 Data Overview
Adalimumab is the #6 most expensive drug in Medicare Part D, costing taxpayers $2.17B in 2023. The top 10 drugs alone account for roughly 20% of all Part D spending.
At $8,997 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $274,591 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $193,175 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Adalimumab
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Anne Marie Holly | Physician Assistant | Rochester, NY | 541 | $4.9M |
| 2 | Ulker Tok | Rheumatology | Tucson, AZ | 481 | $4.3M |
| 3 | Mansoor Ahmed | Rheumatology | Richmond, KY | 519 | $4.0M |
| 4 | Jorge Mundo | Rheumatology | Humacao, PR | 525 | $3.7M |
| 5 | Rajiv Shah | Ophthalmology | Winston Salem, NC | 477 | $3.6M |
| 6 | Luis Salayandia | Rheumatology | El Paso, TX | 448 | $3.6M |
| 7 | Supen Patel | Rheumatology | Florence, SC | 372 | $3.5M |
| 8 | Amarilis Torres | Rheumatology | Zephyrhills, FL | 230 | $3.2M |
| 9 | Ari Hardin | Physician Assistant | Brentwood, TN | 264 | $3.1M |
| 10 | Kayvan Kamali | Rheumatology | Longview, TX | 388 | $3.0M |
| 11 | Ashrito Dayal | Rheumatology | Charlotte, NC | 338 | $3.0M |
| 12 | Jyothi Mallepalli | Rheumatology | Monroe, LA | 392 | $2.9M |
| 13 | Roshan Kotha | Rheumatology | La Mesa, CA | 378 | $2.8M |
| 14 | Fahed Hamadeh | Rheumatology | Oklahoma City, OK | 333 | $2.7M |
| 15 | William Sullivan | Rheumatology | Fairhope, AL | 288 | $2.7M |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 3 | Empagliflozin (Jardiance) | $3.58B | 3,334,784 |
| 4 | Dulaglutide (Trulicity) | $2.99B | 2,175,100 |
| 5 | Rivaroxaban (Xarelto) | $2.45B | 2,628,123 |
| 6 | Adalimumab (Humira(Cf) Pen) | $2.17B | 240,925 |
| 7 | Lenalidomide (Revlimid) | $2.15B | 130,834 |
| 8 | Insulin Glargine,hum.Rec.Anlog (Lantus Solostar) | $1.94B | 3,118,259 |
| 9 | Fluticasone/Umeclidin/Vilanter (Trelegy Ellipta) | $1.81B | 2,046,216 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology